Celanese Corporation Earnings Recaps
Q1 2026
May 7, 2026
The stock dropped 15.4% following the quarter as investors reacted negatively to a cautious outlook and signs of demand weakness across major end markets, undermining confidence in the company’s near-term growth prospects.
Key takeaways
- Management acknowledged weak demand across key end markets, with only transient uplift from order pattern distortions (prebuys) in Q1.
- The guidance for the second half assumes supply chain normalization and a moderate recovery in volumes and margins, reflecting continued uncertainty.
- Despite operating some assets at high utilization (Clear Lake), supply chain challenges and cautious capacity ramp-ups highlight ongoing execution risks.
- Engineered Materials segment shows resilience with pricing actions to offset feedstock inflation, but feedthrough delays persist.
- Equity earnings from benzene-related operations are expected to remain flat versus last year, constrained by recent shutdowns and shipping disruptions.
Q2 2025
Aug 12, 2025
Celanese Corporation reported a mixed performance in Q2 2025, with EPS impacted by weakening demand in key markets, particularly in China and Europe, despite maintaining strong free cash flow projections.
Key takeaways
- Q2 EPS guidance reinforced at $1.25, but demand weakening may delay reaching the $2 per share target.
- Significant inventory reduction efforts resulted in a projected $25 million negative earnings impact in Q3 from Engineered Materials.
- Free cash flow remains a top priority, with expectations set at $700 million to $800 million for the year, translating to approximately $7 per share.
- Continued plans for cost structure improvements and price optimization in distinct market segments are in place to enhance profitability.
- Stability noted in the Americas market despite global demand challenges, indicating potential resilience in some regional operations.